Tiger Global, B Capital Likely To Pick Up Stake In Online Pharmacy Platform PharmEasy: ReportPharmEasy (Source: Entrackr)

Online pharmacy platform PharmEasy which had won the unicorn status during the last fund-raising campaign in April is now said to be set for another round of fund-raising at a valuation of about $1.8 billion, reports Economic Times.

New York-based renowned investment firm Tiger Global and Facebook co-founder Eduardo Saverin’s B Capital are said to be in advanced negotiations to pick up stake in PharmEasy.

While Tiger Global is likely to pump in primary capital in PharmEasy, B Capital is expected to pick up secondary shares from existing investors in the company.

One of PharmEasy’s early backers, Everstone Capital is said to be looking to divest a part of its holding in the company in a transaction that could be about $40 million.

The development comse at a time when PharmEasy is also said to be planning for initial public listing at a valuation of as much as $3 billion.

The online pharmacy is presently clocking monthly sales of around Rs 300 crore. It has also just completed the acquisition of rival Medlife, making it the largest e-pharmacy platform in the country.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber